Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Stock Market

A collection of 10 Posts

Amanta Healthcare Shares Surge After Successful IPO Listing post image

Amanta Healthcare Shares Surge After Successful IPO Listing

Amanta Healthcare IPO lists at 7% premium on stock market debut post image

Amanta Healthcare IPO lists at 7% premium on stock market debut

Amanta Healthcare Shares List At 7% Premium After Strong IPO post image

Amanta Healthcare Shares List At 7% Premium After Strong IPO

Martin Shkreli Reinforces Bearish Bet Against Opendoor, Citing Newegg Comparison post image

Martin Shkreli Reinforces Bearish Bet Against Opendoor, Citing Newegg Comparison

Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald post image

Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald

BioMarin Pharmaceutical Attracts New Institutional Investment Amidst Positive Analyst Outlook post image

BioMarin Pharmaceutical Attracts New Institutional Investment Amidst Positive Analyst Outlook

Amanta Healthcare's Market Debut: IPO Expectations and Expansion Plans post image

Amanta Healthcare's Market Debut: IPO Expectations and Expansion Plans

Market Update: Stocks Edge Up, Biotech Firm Enveda Reaches Unicorn Status post image

Market Update: Stocks Edge Up, Biotech Firm Enveda Reaches Unicorn Status

Technical Analysis: Alkem Labs and Dr. Lal PathLabs Show Bullish Signals post image

Technical Analysis: Alkem Labs and Dr. Lal PathLabs Show Bullish Signals

Amanta Healthcare IPO Opens Today - Check Price, Subscription Status, GMP post image

Amanta Healthcare IPO Opens Today - Check Price, Subscription Status, GMP